ArticleRevista brasileira de enfermagem2026
Ivermectin in Acute Renal Injury Induced by Ischemia-Reperfusion: An Experimental Study in Wistar Rats.
Article in Revista brasileira de enfermagem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesto assess the effect of ivermectin in an experimental model of ischemia-reperfusion as a risk factor.
methodstwenty adult male Wistar rats were randomized into the following groups: Sham: surgical simulation without clamping of the renal pedicles; ischemia: clamping of the renal pedicles for 30 minutes; Sham + ivermectin: 10 mg/kg of ivermectin, orally, once daily for five days; and Ischemia + ivermectin. Physiological parameters such as body weight, water and food intake, renal function (creatinine clearance), and oxidative profile (urinary peroxides and thiobarbituric acid reactive substances) were assessed.
resultsan increase in kidney-to-body weight ratio, serum creatinine, and oxidative stress was observed in animals treated with ivermectin (p<0.05).
conclusionsthe use of ivermectin, associated with the ischemia-reperfusion risk factor, demonstrated nephrotoxic action in Wistar rats, evidenced by impaired renal function and increased oxidative stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.